The Race To The Bottom In The Chinese Pharmaceutical Market Reinforces The Need To Market In The United States

while new drugs may be approved in China, unless they have unique mechanisms of action, they may simply join a race to the bottom in terms of domestic reimbursement. Hence the increasing trend for Chi...

Merck’s Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24%

Stefanie Joho, 27, stands for a portrait at the home of a friend in Penn Valley, PA on Tuesday, May 9, 2017. Joho, who was diagnosed with colon cancer at 22 years old, has been in remission since Febr...